Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAPRESSIM trial
2015-003504-22Phase 4Completed
- Sponsor
- UCB
- Start
- Aug 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypopnea comparing Naloxone infusion with Placebo infusion (2 arms). Primary endpoint: Respiratory depression incidence. Started Aug 2015; status: completed.
02
Drugs
naloxone
03
Conditions
hypopnea
Beyond the preview
Go deeper on 2015-003504-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003504-22.